Treasury
Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi
Middle East Pharmaceutical Industries Co (SASE:4016), d/b/a Avalon Pharma, renewed its one-year bank facility agreement amounting to 104 million Saudi riyals with Banque Saudi Fransi.The Tadawul-listed pharmaceutical company said Thursday the Sharia-compliant facility will be used to fund its working capital.
SASE:4016
